Incorporating direct molecular diagnostics in management algorithms for nontuberculous mycobacteria: Is it high time?

Highlights

• •

  Novel techniques are encouraged to identify nontuberculosis mycobacteria (NTM).

• •

  An algorithm incorporating direct molecular identification of NTM is suggested.

• •

  Rapid NTM identification can assist in decision-making and prompt treatment initiation.

Abstract

Nontuberculous mycobacteria (NTM) are a group of acid-fast mycobacteria other than Mycobacterium tuberculosis complex (MTBC) that cause pulmonary disease that is similar to the disease caused by MTBC. International guidelines for the diagnosis of pulmonary NTM disease are rigid and have remained unchanged for nearly 2 decades. In this opinion piece, we provide a new perspective on the traditional criteria by suggesting a diagnostic algorithm that incorporates direct molecular identification of NTM performed on raw sputum specimens (using Sanger or targeted deep sequencing approaches, among others) paired with traditional culture methods. Our approach ensures a more rapid diagnosis of pulmonary NTM disease, thus, facilitating timeous clinical diagnosis, and prompt treatment initiation, where indicated, and leverages recent advances in novel molecular techniques into routine NTM identification practice.